GLR
VRTX icon

Great Lakes Retirement’s Vertex Pharmaceuticals VRTX Stock Holding History

Great Lakes Retirement’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$904K Buy
2,025
+116
+6% +$54.1K 0.09% 161
2025
Q4 		$865K Buy
1,909
+120
+7% +$51.7K 0.09% 163
2025
Q3 		$701K Buy
1,789
+65
+4% +$27.2K 0.08% 162
2025
Q2 		$768K Sell
1,724
-5
-0.3% -$2.3K 0.09% 156
2025
Q1 		$838K Buy
+1,729
New +$806K 0.11% 153
2024
Q3 		– Sell
-88
Closed -$41.2K – 656
2024
Q2 		$41.2K Buy
+88
New +$38.2K 0.01% 301

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Great Lakes Retirement's VRTX Position: Q1 2026 in Review

Great Lakes Retirement increased its Vertex Pharmaceuticals (VRTX) stake by 6.1% in Q1 2026, buying an estimated $54.1K and bringing the position to 2,025 shares worth $904K. The position accounts for 0.09% of the portfolio, ranked #161.

Great Lakes Retirement first reported a position in VRTX in Q2 2024 and has held it in 6 quarters since. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Great Lakes Retirement held 2,025 shares of Vertex Pharmaceuticals worth $904K as of Q1 2026.
  • Great Lakes Retirement bought 116 Vertex Pharmaceuticals shares in Q1 2026, an estimated $54.1K.
  • Vertex Pharmaceuticals made up 0.09% of Great Lakes Retirement's portfolio in Q1 2026, its #161 holding.
  • Great Lakes Retirement first reported a position in Vertex Pharmaceuticals in Q2 2024 and has held it in 6 quarters since.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Great Lakes Retirement's 13F filing for Q1 2026, filed 6 May 2026.